• Documents
  • Authors
  • Tables
  • Log in
  • Sign up
  • MetaCart
  • DMCA
  • Donate

CiteSeerX logo

Tools

Sorted by:
Try your query at:
Semantic Scholar Scholar Academic
Google Bing DBLP
Results 1 - 10 of 1,929
Next 10 →

Table 1: Hematological indices in chicken blood in chronic ochratoxicosis Group HbG/dl PCV % Heterophils % Lymphocytes %

in Morphological and Functional Evaluation of Chicken Blood Leukocytes in Chronic Ochratoxicosis
by Bartlomiej Janaczyk, Ra Pliszczak-król, Stanislaw Graczyk, Marek Houszka, Kamal Rouibah
"... In PAGE 2: ..., 1979). Those records correspond with earlier findings regarding the occurrence of anemia in the course of ochratoxicosis Considerable decrease in both Hb content (from 7,3 g/dl in group I to 6,2 g/dl in group III) and PCV value (from 31,1% in group I to 26,8% in group III) speak for the above interpretation ( Table1 ). The data obtained due to the analysis of leukocyte pattern of experimental chickens seem to be interesting as well.... In PAGE 2: ... The data obtained due to the analysis of leukocyte pattern of experimental chickens seem to be interesting as well. After ten days of feeding chickens with fodder containing ochratoxin there was recorded the increase in percentage of heterophils, accompanied by the decreased percentage of lymphocytes ( Table1 ). Such a behavior of leukocytes in blood is similar to the changes characteristic for adaptation processes, namely for stress (Gross and Siegel, 1983; Graczyk, 1999).... ..."

Table 2. Demographic Data for the Chronic Pain Patients

in unknown title
by unknown authors 2006
"... In PAGE 4: ...7%) in individually relatively small numbers. The genotyping data for the chronic pain popula- tion is provided in Table2 . The MOR A118G genotype distribution in chronic pain patient samples was in Hardy-Weinberg equilibrium (P H11005 0.... ..."

Table 4: Chronic disease surveillance: Gaps and solutions

in Executive Summary....................................................... iv
by Centre For Surveillance Coordination, Catalogue No 2003
"... In PAGE 2: .................18 Table4 : Chronic disease surveillance: Gaps and solutions .... In PAGE 23: ...2 What is needed to enhance chronic disease surveillance? Canada is moving towards the establishment of electronic health records that will track health information at the level of the individual - perhaps the ultimate solution to enhancing chronic disease surveillance. However, this is not an immediate solution, and action is needed in a number of areas to make current surveillance processes more effective ( Table4 below). When reviewing this information, it is important to keep in mind that good surveillance does not depend on perfect data and a perfect system - it depends on adequate data, available with enough... ..."

Table 1 Systematic reviews of acupuncture for chronic pain

in unknown title
by unknown authors
"... In PAGE 3: ...18-26 D2. Chronic pain Several systematic reviews have evaluated the effectiveness of acupuncture for the treatment of chronic pain (see Table1 ).27-45 Some systematic reviews have examined particular diagnoses, such as headache or back pain, whereas others have included studies across a range of chronic pain conditions.... In PAGE 5: ...Table1 Systematic reviews of acupuncture for chronic pain cont. sham, other, no treatment sham, other treatments sham, other, no treatment sham, no treatment, different acupuncture sham 7 RCT 3 RCT, 4 CS 7 RCT, 4 RCT/CCT, 2 RCT 2 RCT, 7 CCT, 9 CS 1 RCT, 2CCT y/y/y/n/n y/y/y/y/n y/p/n/y/n n/p/n/y/n y/p/y/n/n Strong evidence that acupuncture is more effective than sham acupuncture for pain.... ..."

Table 2. Definitions of chronic, accelerated and blastic phase.

in Background and Objectives. The new Abl tyrosine kinase
by Inhibitor Imatinib Imatinib, David Marin, Sarah Marktel, Marco Bua, Lorraine Armstrong, John M. Goldman, Jane F. Apperley, Eduardo Olavarria
"... In PAGE 2: ...14 Currently we consider that for patients in blastic transformation imatinib is best considered as part of a treatment strategy that also incorporates con- ventional cytotoxic drugs and/or allogeneic or autologous SCT. CML in accelerated phase The responses of patients in accelerated phase to imatinib vary according to the definition of accel- eration ( Table2 and Figure 1). In our series of 106 patients in accelerated phase defined according to the World Health Organization criteria,15 the actu- arial survival and progression-free survivals at 18 months were 73% and 37%, respectively.... ..."

Table 7: Refusals to CATI Calls, Chronic Nonrespondents

in Improvement Of Response Rates On The Manufacturers' Shipments, Inventories, And Orders Survey With CATI
by Douglas Bond, Richard Sigman

Table 14: Decomposition of Changes in Chronic Conditions

in Long-Term Declines in Disability Among Older Men: Medical Care, Public Health, and Occupational Change
by Dora L. Costa, Robert Margo, Louis Nguyen, Nevin Scrimshaw, Dora L. Costa, Jel No. I, Dora L. Costa 2000
"... In PAGE 37: ... Table14 summarizes the relative impact of infectious disease and occupation on func- tional disability. (Results for paralysis and blindness are not presented because change in func- tional form, not changes in prevalence rates were more important determinants of declines in these measures of functional disability.... In PAGE 37: ... (Results for paralysis and blindness are not presented because change in func- tional form, not changes in prevalence rates were more important determinants of declines in these measures of functional disability.) Because Table14 cannot account for unobserved infec- tious disease episodes or occupational hazards, it probably underestimates the role of reduced infectious disease rates and occupational risks in lowering functional disability. On average, Table 14 shows that 9 percent of the decline in difficulty in walking and in bending between the Union Army data and NHANES is accounted for by reduced infectious disease rates and 7 percent by occupational shifts.... In PAGE 37: ...) Because Table 14 cannot account for unobserved infec- tious disease episodes or occupational hazards, it probably underestimates the role of reduced infectious disease rates and occupational risks in lowering functional disability. On average, Table14 shows that 9 percent of the decline in difficulty in walking and in bending between the Union Army data and NHANES is accounted for by reduced infectious disease rates and 7 percent by occupational shifts. These figures are probably underestimates because of unobserved infectious disease episodes and reduced job risk within occupation group.... In PAGE 37: ... Between 1900 and NHANES occupational shifts account for only 2 percent of the decline in difficulty in bending and reductions in infectious disease for 12 percent. Table14 also shows the relative importance of occupational shifts and infectious disease reductions in accounting for differences between the Union Army sample and NHIS. Because the independent disease variables in the NHIS specification did not include musculoskeletal conditions, infectious disease plays a more important role in disability declines than occupational shifts.... ..."

Table 1. Important attributes in the chronic hepatitis data.

in Application of PrototypeLines to Chronic Hepatitis Data Takeshi Watanabe 1, Einoshin Suzuki 1, Hideto Yokoi 2, and
by Katsuhiko Takabayashi

Table 1: Chronic and Communicable Disease - Challenges for Surveillance.7-14 issue chronic communicable

in Executive Summary....................................................... iv
by Centre For Surveillance Coordination, Catalogue No 2003
"... In PAGE 2: ....4 Table1 : Chronic and Communicable Disease - Challenges for Surveillance .... In PAGE 9: ...e.g., administrative data sets). Types of data, sources of data, methods for collecting data, approaches to interpretation and analysis, and temporality issues may differ for communicable and chronic disease surveillance.7 It is useful to consider the major distinctions (as noted in Table1 below) so that the differences are well understood and the similarities that facilitate integration into an overall public health information system are clearly identified. Table 1: Chronic and Communicable Disease - Challenges for Surveillance.... ..."

Table 5: Determinants of transient and chronic poverty OLS with HCSE Transient poverty Chronic poverty

in Policy Research Working Paper :. 1616
by Transient Poverty In
"... In PAGE 22: ... Thus for the chronic poverty model, we use the 90 percentile to quot;center quot; our distribution while for the transitory model, we use the 75d percentile. quot;5 Table5 reports the parameter estimates from the censored quantile regressions. Most physical capital variables affect the transient and chronic poverty components in a similar direction.... ..."
Next 10 →
Results 1 - 10 of 1,929
Powered by: Apache Solr
  • About CiteSeerX
  • Submit and Index Documents
  • Privacy Policy
  • Help
  • Data
  • Source
  • Contact Us

Developed at and hosted by The College of Information Sciences and Technology

© 2007-2019 The Pennsylvania State University